Global Ganja Report

Political space for cannabis is generally on the upswing, but there are some intersecting trends that advocates will need to keep a sharp eye on in the coming year. Corporate cannabis will increase pressure on independent producers, while prohibitionists will try to leverage the vape health scare for anti-cannabis propaganda. And the cannabis industry's own terminology may be actually adding to the confusion.

Much media hype anticipates an imminent cannabis boom in Africa, and foreign investment is indeed pouring into a few key countries on the continent. But some dreams have also come to naught—and a few initiatives have displayed some of the worst tendencies of corporate agribusiness in the developing world.

2019 saw advances for cannabis freedom on both the national and global stage—but also some near-misses, from New York state to Mexico, which have left activists frustrated if no less determined. As advocates prepare to carry the fight into 2020, here's a review of what was achieved—or almost achieved—over the past 12 months.

Brazil's limited medical marijuana program takes a step forward with new regulations allowing importation of THC products. Cultivation within the country, however, will be confined to "hemp"—that is, CBD-only strains. And even that is proceeding very slowly. The far-right government of Jair Bolsonaro meanwhile continues its hardline policies in the face of fast-escalating narco-violence.

There is a discomforting sense that Mexico is perpetually on the eve of cannabis legalization, as the country's Congress wins a six-month extension from the Supreme Court to pass a law freeing the herb. But foreign capital is already eyeing Mexico's emergent legal cannabis sector—even amid a terrifying escalation in the bloody cartel wars. 

Hemp and hemp-derived CBD were officially legalized under the 2018 Farm Bill, but the US Department of Agriculture has failed to bring its regulations into conformity with the new federal law—until now. Interim regs have just been issued by the USDA, with a 60-day public comment period to follow—meaning a final rule will likely be in place in time for next year's planting season.

Having cannabis removed from the federal list of controlled substances has long been the holy grail of legalization advocates. Several bills have now been introduced on Capitol Hill to do exactly that. Do any stand a chance of becoming law in the current polarized climate?

As the cannabis industry is embraced by corporate power and finance capital, the patenting of strains, products and applications is an increasing concern. But the international patchwork of legality makes for a confusing environment. Illegality has served as a paradoxical break on privatizing of varieties. Growers and advocates are devising means to protect the genetic commons in the new cannabis order.